A detailed history of Sphera Funds Management Ltd. transactions in Merus N.V. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 147,633 shares of MRUS stock, worth $7.33 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
147,633
Previous 147,633 -0.0%
Holding current value
$7.33 Million
Previous $8.74 Million 15.57%
% of portfolio
1.35%
Previous 1.28%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$39.81 - $60.2 $67,677 - $102,340
-1,700 Reduced 1.14%
147,633 $8.74 Million
Q1 2024

May 15, 2024

SELL
$28.03 - $51.82 $2.27 Million - $4.2 Million
-81,000 Reduced 35.17%
149,333 $6.72 Million
Q4 2023

Feb 14, 2024

SELL
$20.06 - $28.66 $461,379 - $659,180
-23,000 Reduced 9.08%
230,333 $6.33 Million
Q3 2023

Nov 14, 2023

SELL
$20.13 - $27.29 $503,250 - $682,250
-25,000 Reduced 8.98%
253,333 $5.97 Million
Q2 2023

Aug 14, 2023

SELL
$18.33 - $27.18 $1.08 Million - $1.59 Million
-58,660 Reduced 17.41%
278,333 $7.33 Million
Q1 2023

May 15, 2023

BUY
$14.25 - $20.5 $285,000 - $410,000
20,000 Added 6.31%
336,993 $6.2 Million
Q4 2022

Feb 14, 2023

BUY
$12.8 - $23.66 $46,937 - $86,761
3,667 Added 1.17%
316,993 $4.9 Million
Q3 2022

Nov 14, 2022

SELL
$18.64 - $28.93 $1.79 Million - $2.77 Million
-95,835 Reduced 23.42%
313,326 $6.28 Million
Q2 2022

Aug 15, 2022

BUY
$13.98 - $29.25 $279 - $585
20 Added 0.0%
409,161 $9.26 Million
Q1 2022

May 16, 2022

BUY
$23.58 - $30.91 $1.61 Million - $2.11 Million
68,190 Added 20.0%
409,141 $10.8 Million
Q4 2021

Feb 14, 2022

BUY
$20.0 - $32.29 $630,480 - $1.02 Million
31,524 Added 10.19%
340,951 $10.8 Million
Q3 2021

Nov 15, 2021

BUY
$16.48 - $27.23 $377,738 - $624,138
22,921 Added 8.0%
309,427 $6.81 Million
Q2 2021

Aug 17, 2021

BUY
$20.0 - $25.48 $4.19 Million - $5.34 Million
209,514 Added 272.12%
286,506 $6.04 Million
Q1 2021

May 17, 2021

BUY
$16.14 - $29.11 $1.24 Million - $2.24 Million
76,992 New
76,992 $1.61 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.